19 May 2013
Keywords: zeneca, accolate, effective, asthma, selective, leukotriene, antagonist
Article | 19 April 1993
Zeneca's selective leukotriene antagonist Accolate (ICI 204,219) is well-tolerated and shows a significant dose response in objective and subjective measurements in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.